Reverse Transcriptase Enzyme - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241144

Publication Date:

October 31, 2024

Pages:

130

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
The global market for Reverse Transcriptase Enzyme was estimated to be worth US$ 321.7 million in 2023 and is forecast to a readjusted size of US$ 501.1 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030
Thermo Fisher, Promega, Roche, Bio-Rad and Takara Bio are the main producers of Reverse Transcriptase, the top 3 hold nearly 40% of the whole market. North America is the main market, which holds about 40% of the global marketshare.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Reverse Transcriptase Enzyme, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Reverse Transcriptase Enzyme by region & country, by Type, and by Application.
The Reverse Transcriptase Enzyme market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reverse Transcriptase Enzyme.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
Takara Bio
Biomatik
New England Biolabs
QIAGEN
Promega Corporation
Toyobo
AMS Biotechnology
Lucigen Corporation
Bio-Helix
Fapon Biotech
Nanjing Vazyme Biotech
Shanghai Yeasen Biotechnology
Beijing TIANGEN Biotech
Segment by Type:
Reverse Transcriptase Enzyme Reagent
Reverse Transcriptase Enzyme Primer
Segment by Application
Hospitals
BIotech Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Reverse Transcriptase Enzyme manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Reverse Transcriptase Enzyme in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Reverse Transcriptase Enzyme in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Reverse Transcriptase Enzyme Product Introduction
1.2 Global Reverse Transcriptase Enzyme Market Size Forecast
1.3 Reverse Transcriptase Enzyme Market Trends & Drivers
1.3.1 Reverse Transcriptase Enzyme Industry Trends
1.3.2 Reverse Transcriptase Enzyme Market Drivers & Opportunity
1.3.3 Reverse Transcriptase Enzyme Market Challenges
1.3.4 Reverse Transcriptase Enzyme Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Reverse Transcriptase Enzyme Players Revenue Ranking (2023)
2.2 Global Reverse Transcriptase Enzyme Revenue by Company (2019-2024)
2.3 Key Companies Reverse Transcriptase Enzyme Manufacturing Base Distribution and Headquarters
2.4 Key Companies Reverse Transcriptase Enzyme Product Offered
2.5 Key Companies Time to Begin Mass Production of Reverse Transcriptase Enzyme
2.6 Reverse Transcriptase Enzyme Market Competitive Analysis
2.6.1 Reverse Transcriptase Enzyme Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Reverse Transcriptase Enzyme Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reverse Transcriptase Enzyme as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Reverse Transcriptase Enzyme Reagent
3.1.2 Reverse Transcriptase Enzyme Primer
3.2 Global Reverse Transcriptase Enzyme Sales Value by Type
3.2.1 Global Reverse Transcriptase Enzyme Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Reverse Transcriptase Enzyme Sales Value, by Type (2019-2030)
3.2.3 Global Reverse Transcriptase Enzyme Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 BIotech Companies
4.1.3 Others
4.2 Global Reverse Transcriptase Enzyme Sales Value by Application
4.2.1 Global Reverse Transcriptase Enzyme Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Reverse Transcriptase Enzyme Sales Value, by Application (2019-2030)
4.2.3 Global Reverse Transcriptase Enzyme Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Reverse Transcriptase Enzyme Sales Value by Region
5.1.1 Global Reverse Transcriptase Enzyme Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Reverse Transcriptase Enzyme Sales Value by Region (2019-2024)
5.1.3 Global Reverse Transcriptase Enzyme Sales Value by Region (2025-2030)
5.1.4 Global Reverse Transcriptase Enzyme Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Reverse Transcriptase Enzyme Sales Value, 2019-2030
5.2.2 North America Reverse Transcriptase Enzyme Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Reverse Transcriptase Enzyme Sales Value, 2019-2030
5.3.2 Europe Reverse Transcriptase Enzyme Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Reverse Transcriptase Enzyme Sales Value, 2019-2030
5.4.2 Asia Pacific Reverse Transcriptase Enzyme Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Reverse Transcriptase Enzyme Sales Value, 2019-2030
5.5.2 South America Reverse Transcriptase Enzyme Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Reverse Transcriptase Enzyme Sales Value, 2019-2030
5.6.2 Middle East & Africa Reverse Transcriptase Enzyme Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Reverse Transcriptase Enzyme Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Reverse Transcriptase Enzyme Sales Value
6.3 United States
6.3.1 United States Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.3.2 United States Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.4.2 Europe Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.5.2 China Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.5.3 China Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.6.2 Japan Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.7.2 South Korea Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.8.2 Southeast Asia Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Reverse Transcriptase Enzyme Sales Value, 2019-2030
6.9.2 India Reverse Transcriptase Enzyme Sales Value by Type (%), 2023 VS 2030
6.9.3 India Reverse Transcriptase Enzyme Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Reverse Transcriptase Enzyme Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Bio-Rad
7.2.1 Bio-Rad Profile
7.2.2 Bio-Rad Main Business
7.2.3 Bio-Rad Reverse Transcriptase Enzyme Products, Services and Solutions
7.2.4 Bio-Rad Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.2.5 Bio-Rad Recent Developments
7.3 Takara Bio
7.3.1 Takara Bio Profile
7.3.2 Takara Bio Main Business
7.3.3 Takara Bio Reverse Transcriptase Enzyme Products, Services and Solutions
7.3.4 Takara Bio Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.3.5 Biomatik Recent Developments
7.4 Biomatik
7.4.1 Biomatik Profile
7.4.2 Biomatik Main Business
7.4.3 Biomatik Reverse Transcriptase Enzyme Products, Services and Solutions
7.4.4 Biomatik Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.4.5 Biomatik Recent Developments
7.5 New England Biolabs
7.5.1 New England Biolabs Profile
7.5.2 New England Biolabs Main Business
7.5.3 New England Biolabs Reverse Transcriptase Enzyme Products, Services and Solutions
7.5.4 New England Biolabs Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.5.5 New England Biolabs Recent Developments
7.6 QIAGEN
7.6.1 QIAGEN Profile
7.6.2 QIAGEN Main Business
7.6.3 QIAGEN Reverse Transcriptase Enzyme Products, Services and Solutions
7.6.4 QIAGEN Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.6.5 QIAGEN Recent Developments
7.7 Promega Corporation
7.7.1 Promega Corporation Profile
7.7.2 Promega Corporation Main Business
7.7.3 Promega Corporation Reverse Transcriptase Enzyme Products, Services and Solutions
7.7.4 Promega Corporation Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.7.5 Promega Corporation Recent Developments
7.8 Toyobo
7.8.1 Toyobo Profile
7.8.2 Toyobo Main Business
7.8.3 Toyobo Reverse Transcriptase Enzyme Products, Services and Solutions
7.8.4 Toyobo Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.8.5 Toyobo Recent Developments
7.9 AMS Biotechnology
7.9.1 AMS Biotechnology Profile
7.9.2 AMS Biotechnology Main Business
7.9.3 AMS Biotechnology Reverse Transcriptase Enzyme Products, Services and Solutions
7.9.4 AMS Biotechnology Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.9.5 AMS Biotechnology Recent Developments
7.10 Lucigen Corporation
7.10.1 Lucigen Corporation Profile
7.10.2 Lucigen Corporation Main Business
7.10.3 Lucigen Corporation Reverse Transcriptase Enzyme Products, Services and Solutions
7.10.4 Lucigen Corporation Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.10.5 Lucigen Corporation Recent Developments
7.11 Bio-Helix
7.11.1 Bio-Helix Profile
7.11.2 Bio-Helix Main Business
7.11.3 Bio-Helix Reverse Transcriptase Enzyme Products, Services and Solutions
7.11.4 Bio-Helix Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Helix Recent Developments
7.12 Fapon Biotech
7.12.1 Fapon Biotech Profile
7.12.2 Fapon Biotech Main Business
7.12.3 Fapon Biotech Reverse Transcriptase Enzyme Products, Services and Solutions
7.12.4 Fapon Biotech Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.12.5 Fapon Biotech Recent Developments
7.13 Nanjing Vazyme Biotech
7.13.1 Nanjing Vazyme Biotech Profile
7.13.2 Nanjing Vazyme Biotech Main Business
7.13.3 Nanjing Vazyme Biotech Reverse Transcriptase Enzyme Products, Services and Solutions
7.13.4 Nanjing Vazyme Biotech Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.13.5 Nanjing Vazyme Biotech Recent Developments
7.14 Shanghai Yeasen Biotechnology
7.14.1 Shanghai Yeasen Biotechnology Profile
7.14.2 Shanghai Yeasen Biotechnology Main Business
7.14.3 Shanghai Yeasen Biotechnology Reverse Transcriptase Enzyme Products, Services and Solutions
7.14.4 Shanghai Yeasen Biotechnology Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.14.5 Shanghai Yeasen Biotechnology Recent Developments
7.15 Beijing TIANGEN Biotech
7.15.1 Beijing TIANGEN Biotech Profile
7.15.2 Beijing TIANGEN Biotech Main Business
7.15.3 Beijing TIANGEN Biotech Reverse Transcriptase Enzyme Products, Services and Solutions
7.15.4 Beijing TIANGEN Biotech Reverse Transcriptase Enzyme Revenue (US$ Million) & (2019-2024)
7.15.5 Beijing TIANGEN Biotech Recent Developments
8 Industry Chain Analysis
8.1 Reverse Transcriptase Enzyme Industrial Chain
8.2 Reverse Transcriptase Enzyme Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Reverse Transcriptase Enzyme Sales Model
8.5.2 Sales Channel
8.5.3 Reverse Transcriptase Enzyme Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Bio-Rad
Takara Bio
Biomatik
New England Biolabs
QIAGEN
Promega Corporation
Toyobo
AMS Biotechnology
Lucigen Corporation
Bio-Helix
Fapon Biotech
Nanjing Vazyme Biotech
Shanghai Yeasen Biotechnology
Beijing TIANGEN Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂